Clinical Trials Logo

Healthy Adults clinical trials

View clinical trials related to Healthy Adults.

Filter by:

NCT ID: NCT04845464 Completed - Healthy Adults Clinical Trials

Sleep Quality and Cognition in Young Adults

Start date: March 8, 2019
Phase:
Study type: Observational

Sleep quality is impaired in young adults due to current conditions. Recent studies emphasize that this situation may also affect the cognitive status of individuals. The aim of this study was to investigate the relationship between sleep quality and cognitive status in young adults. A total of 122 young adults (61 female, 61 male) aged between 18 to 25 and studied at Istanbul Medipol University, Faculty of Health Sciences, were included in the study. Individuals were evaluated with "Pittsburgh Sleep Quality Index (PSQI)" for sleep quality; with "Montreal Cognitive Status Scale (MoCA)" for cognitive status, with "STROOP Test" for selective attention; with "Verbal Fluency Test" for sustained attention; with "WMS-R digit Span Test" for auditory attention

NCT ID: NCT04844775 Active, not recruiting - Healthy Adults Clinical Trials

A Prophylactic HIV Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Clade C DREP Alone and in Combination With a Clade C ENV Protein in Healthy HIV-uninfected Adults

Start date: August 5, 2022
Phase: Phase 1
Study type: Interventional

EHVA P01 is an international, phase I, prophylactic HIV vaccine trial to evaluate the safety and immunogenicity of HIV Clade C DREP alone and in Combination with a Clade C ENV protein in healthy HIV-uninfected adults.

NCT ID: NCT04842682 Recruiting - Healthy Adults Clinical Trials

Dose Escalation Trial of CD40.HIVRI.Env Vaccine Combined or Not With a DNA-HIV-PT123 HIV-1 Vaccine in Healthy Volunteers

Start date: March 29, 2021
Phase: Phase 1
Study type: Interventional

Multicenter double-blind placebo controlled phase I dose-escalation trial that will be conducted in France and Switzerland to evaluate different dose levels of CD40.HIVRI.Env (adjuvanted with Hiltonol) alone and in co-administration with DNA-HIV-PT123. A total of 72 eligible healthy participants will be recruited into 6 groups. Within each group, participants will be randomized in a double blind manner to active intervention or placebo in a 5:1 ratio. Enrolment into a given group (other than group "Solo 0.3") will open sequentially depending on the " go-criterion " based on the safety data of the preceding group(s). The primary objective is to assess the safety of three dose levels of CD40.HIVRI.Env (0.3; 1; 3 mg) adjuvanted with Poly-ICLC (Hiltonol®), alone and in combination with DNA-HIV-PT123, administered at weeks 0, 4 and 24 in healthy participants. Secondary objectives are to assess the capacity of poly-ICLC-adjuvanted CD40.HIVRI.Env alone and in combination with DNA-HIV-PT123 to elicit immune responses against HIV (immunogenicity): - Humoral (antibody) responses ; - B-cell responses ; - T-cell responses.

NCT ID: NCT04800614 Completed - Healthy Adults Clinical Trials

A Study to Explore the Effect of Food Before a Single Dose of Sitravatinib

Start date: March 15, 2021
Phase: Phase 1
Study type: Interventional

An Open-label, Randomized, Three-period, Crossover Study of the Effect of Food on the Pharmacokinetics of a Single Oral Dose of Sitravatinib in Healthy Adult Subjects

NCT ID: NCT04759612 Completed - Healthy Adults Clinical Trials

Is Self-action Observation More Effective Than Observing Another Person's Action?

Start date: June 4, 2021
Phase: N/A
Study type: Interventional

The aim of the study is to compare the possible effects of self-action observation and observation of another person's action on upper extremity functionality, cognitive functions and reaction times.

NCT ID: NCT04724304 Completed - Healthy Adults Clinical Trials

Myocardial Blood Volume Measurement by Real-Time Myocardial Perfusion Echocardiography Correlates to Myocardial Compressibility by Cardiac Magnetic Resonance Imaging in Healthy Subjects

Start date: February 9, 2021
Phase: N/A
Study type: Interventional

This study is being done to find out the normal amount of blood within the heart muscle and the variations in this blood flow between a cardiac MRI and TTE.

NCT ID: NCT04677920 Active, not recruiting - Healthy Adults Clinical Trials

The Healthy Cookie Energy Study: Understanding How Healthy Cookies Affect Mitochondrial Biology

HCES
Start date: September 7, 2020
Phase: N/A
Study type: Interventional

The proposed research is an intervention and feasibility pilot trial designed to determine if short-term consumption of healthy cookies made with an oil rich in linoleic acid can influence mitochondria biology in white blood cells and muscle. The hypothesis of the study is that consuming 1 healthy cookie rich in linoleic acid each day for two weeks will improve mitochondrial biology in white blood cells and muscle.

NCT ID: NCT04666181 Completed - Healthy Adults Clinical Trials

Cortical Activation and Cognitive-Motor Learning

Co-ACT&LEARN
Start date: January 15, 2021
Phase: N/A
Study type: Interventional

The purpose of this research study is to assess the effects of dual-task training using a dynamic balance task and an auditory reaction time task on dual-task performance in healthy young adults and to assess the cortical activity within the prefrontal and sensorimotor cortices in response to dual-task training using functional near infrared spectroscopy (fNIRS).

NCT ID: NCT04596709 Completed - Healthy Adults Clinical Trials

Investigation of Blood Glucose and Insulin Response After Intake of Vitalose

Start date: October 22, 2020
Phase: N/A
Study type: Interventional

The aim of this study is to assess the postprandial glucose and insulin response of Vitalose.

NCT ID: NCT04573426 Completed - Obesity Clinical Trials

Pain and Acetaminophen in Women Study

PAWS
Start date: November 15, 2019
Phase:
Study type: Observational

The purpose of this study is to evaluate the influence of acetaminophen on pain response and inflammation.